Thaum Lub Rau Hli 2023, Xinhua Pharmaceutical tau xa cov ntaub ntawv thov rau npe rau kev tso cai ua lag luam ntawm ethyl eicosapentaenoate (ib qho tshuaj muaj txiaj ntsig rau kev tsim khoom hauv tsev) mus rau National Medical Products Administration (NMPA), thiab daim ntawv thov raug lees txais. Thaum lub Tsib Hlis 2025, lub tuam txhab tau txais covDaim Ntawv Ceeb Toom Pom Zoo rau Kev Lag Luam Kev Siv Tshuaj Siv Tshuaj Muaj Tshuaj, nrog rau kev txheeb xyuas qhov xaus yog "kev pom zoo rau kev sau npe".
Raws li kev tswj hwm kev noj haus, cov khoom no yog siv los txo cov qib triglyceride hauv cov neeg laus uas muaj hypertriglyceridemia hnyav (Ntau dua lossis sib npaug li 500mg / dL). Thaum siv ua ke nrog statins, nws tau qhia rau cov neeg laus uas kuaj pom muaj kab mob plawv lossis ntshav qab zib mellitus nrog tsawg kawg 2 lwm yam kab mob plawv, thiab hypertriglyceridemia concurrent (Ntau dua lossis sib npaug li 150mg / dL), kom txo tau qhov kev pheej hmoo ntawm cov kab mob plawv.
Cov khoom no tuaj yeem siv rau ob qho tib si tshuaj thiab khoom noj qab haus huv. Raws li cov ntaub ntawv txheeb cais, lub ntiaj teb kev muag khoom ntim ntawm ethyl eicosapentaenoate mus txog kwv yees li $ 1.838 billion hauv 2023.
